Bromatech is a Bio-tech company that conducts research on the properties of bacteria since 1985. At the forefront of development of probiotics for human use, Bromatech is now an established company with a clear product-offering for the natural treatment of the digestive system. By means of laboratory testing and restless gathering of clinical data, the company continually develops its own formulations. Scientific works and medical literature support our products.
The strain specificity and efficacy of its probiotic products differentiate Bromatech from other companies. To promote advancements in the understanding of the microbiome, it has founded congresses, seminars, academic courses and scholarships. www.bromatech.info
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.
Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs around 6,000 people worldwide, has its own operating subsidiaries in nearly 60 countries, and markets its products in 110 countries. Learn more at www.ferring.com
A key global player in fermentation for more than a century, Lesaffre, with a 2,2 billion euro turnover, counts 11,000 employees established on all continents. On the strength of this experience, we work to find ever more relevant answers to the needs of food, health and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms.
To nourish 9 billion people, in a healthy way, in 2050 is a major issue. We believe that fermentation is one of the most promising answers to this challenge.
Working together to better nourish and protect the planet.
BioGaia is a Swedish world-leading probiotic company that has been at the forefront of microbiome research for more than 30 years. BioGaia develops, markets and sells probiotic products with documented health benefits. To date, over 200 articles on clinical trials with BioGaia’s probiotic strains have been published.
The products are sold by nutrition and pharmaceutical companies in more than 100 countries. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com